Memo from the Director, NIH Office of Biotechnology
Activities, issued 12/6/2004. This memo reiterates the NIH
policy that all funded research involving recombinant DNA molecules "must
follow the provisions for containment and biosafety oversight set forth
in the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH
Guidelines)." The memo goes on to state that "failure
to adhere to the NIH Guidelines can result in suspension or
termination of NIH funding for this type of research or lead to a
requirement for prior NIH approval of any or all recombinant DNA projects
at the institution." Click HERE to
read the complete memo. A link to the NIH Guidelines is also available
on the Web LInks page.
_______________________________________________
UAF is an affirmative action/equal
opportunity employer and educational institution.
